BioScience Health Innovations, Inc. (BHIC) stock
BHICOTCServices-Computer Processing & Data PreparationFiscal year ends December 31
$6.78+0.00 (0.00%)
Close on Oct 16, 2026Market cap $79.22MP/E –Yield –
BioScience Health Innovations gross margin
Gross margin is gross profit as a percentage of revenue.
BioScience Health Innovations's gross margin for the twelve months ending Jun 30, 2026 was 53.8%. For fiscal 2025 it was 57.0%, against 70.9% the year before.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 57.0% | −14.0 |
| FY2024 | Dec 31, 2024 | 70.9% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026CQ2 2026 | Jun 30, 2026 | 63.6% | +2.5 |
| Q1 FY2026CQ1 2026 | Mar 31, 2026 | 64.7% | −8.4 |
| Q4 FY2025CQ4 2025 | Dec 31, 2025 | 36.4% | −19.2 |
| Q3 FY2025CQ3 2025 | Sep 30, 2025 | 61.7% | −12.4 |
| Q2 FY2025CQ2 2025 | Jun 30, 2025 | 61.1% | −19.7 |
| Q1 FY2025CQ1 2025 | Mar 31, 2025 | 73.0% | −11.5 |
| Q4 FY2024CQ4 2024 | Dec 31, 2024 | 55.6% | – |
| Q3 FY2024CQ3 2024 | Sep 30, 2024 | 74.1% | – |
| Q2 FY2024CQ2 2024 | Jun 30, 2024 | 80.8% | – |
| Q1 FY2024CQ1 2024 | Mar 31, 2024 | 84.6% | – |
See a number that looks wrong?